NOTTINGHAM, UNITED KINGDOM - Dec 3, 2013 - Exco InTouch, the leading provider of patient engagement and data capture solutions for clinical research and healthcare providers, is taking part in an mHealth Solutions session regarding patient-centric clinical trials at the annual mHealth Summit on Tuesday, 10 December 2013. 

The mHealth Summit, five years in the making, is now established as the largest mobile health event in the world, and will be held 8-11 December 2013 in Washington DC, USA. The Exco InTouch session will examine the ways mobile and mobile-enabled technology are changing clinical research across all trial phases and driving the adoption of a patient-centric and outcomes-based model for health care.

Delegates are set to discover how mobile health solutions - from apps and sensors through to health management platforms - are reducing trial costs, improving patient recruitment and retention, and facilitating real-time data capture for analysis.

Industry leaders including Tim Davis, CEO and Co-Founder of Exco InTouch, together with Craig Lipset, Clinical Innovation, Pfizer and Matt Hendricks, Principal, Pharmica Consulting, will drive the session. They will present real case studies and discuss opportunities for the utilization of mobile technology in support of adaptive trials to improve trial efficiency while maintaining quality and compliance - from patient-reported outcomes through to remote monitoring of therapeutic use, response and adherence. Tim Davis will highlight three case studies including triggering responses in vaccine safety surveillance, capturing events in cardiovascular outcomes and advancing community health models. 

He commented: "mHealth programs are having a highly transformational impact in terms of making patient reported outcomes in clinical trials highly efficient with significant improvements to both performance and clinical implementation."   

About Exco InTouch

Exco InTouch is the leading provider of patient engagement and data capture solutions to support Clinical, Late Phase and mHealth programs for leading healthcare and biopharmaceutical companies. Placing the patient at its heart, our proven technology can be employed on any device, empowering the patient to be more involved in their healthcare and ultimately leading to better health outcomes. Using a combination of patented software and services our technology can be scaled up to match clients' global requirements and our trusted, low risk applications mean that you can be confident that your data is secure and protected, in line with global regulatory and data protection requirements.

Our solutions capitalize upon global mobile device and internet usage, using a device independent approach enabling involvement which integrates into daily life - resulting in motivated and compliant patients across a wealth of therapeutic, demographic and geographic programs in clinical and commercial settings.

Since 2004, Exco InTouch have engaged with over 750,000 subjects across 85 countries, over 8000 hospitals and clinics, in 70 languages and 16 of the top 20 pharmaceutical companies have deployed our technology. 

For media enquiries, please contact Tristan Jervis or Alex Heeley on +44 (0) 207 203 6740 or e-mail: t.jervis@defacto.com or a.heeley@defacto.com.